NASDAQ · Biotechnology

Exicure, Inc. (XCUR) Stock

$1.05 +5.00% NASDAQ: XCUR Healthcare

Valuation

MetricValue
Price$1.05
Market Cap$6.69M
P/E Ratio-0.87
P/B Ratio7.44
P/S Ratio0.00
EPS (TTM)$-0.79
52-Week High$9.48
52-Week Low$0.96
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-237.91%
ROA-72.69%
ROCE-101.07%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio1.25

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$29.0M$0$1.0M$0
Operating Profit$-63.0M$-2.0M$-15.0M$-12.0M$-10.0M
Net Profit$-64.0M$-3.0M$-17.0M$-10.0M$-5.0M
EPS$-21.70$-0.56$-2.11$-1.59$-0.79
Op Margin12950.1%-6.3%—-2446.4%—

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$65.0M$23.0M$12.0M$15.0M$14.0M
Total Liabilities$54.0M$8.0M$9.0M$8.0M$10.0M
Cash$35.0M$9.0M$1.0M$13.0M$4.0M
Borrowings$15.0M$7.0M$7.0M$6.0M$0

Latest News

Exicure Announces Board and Committee Changes GlobeNewswire · Jun 30, 2026 Exicure Announces Receipt of Nasdaq Notice Regarding Minimum Stockholders’ Equity Requirement GlobeNewswire · Jun 10, 2026 Exicure Announces Receipt of Nasdaq Delinquency Notice and Filing of Form 10-Q GlobeNewswire · Jun 1, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-35.0M$-36.0M$-10.0M$-3.0M$-9.0M
Investing Cash Flow$42.0M$5.0M$-1.0M$0$-2.0M
Financing Cash Flow$0$-1.0M$-2.0M$0$0
Net Cash Flow$9.0M$-34.0M$-8.0M$10.0M$-9.0M
Free Cash Flow$-36.0M$-36.0M$-10.0M$-3.0M$-9.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.01
EV / EBITDA-0.65
FCF Yield-87.87%
Quick Ratio0.56
Interest Coverage-7304.00
Return 1Y-76.35%
Return 3Y-76.18%
Return 5Y-99.23%

Ownership

Insiders Held42.59%
Institutions Held2.69%
Institutions Float Held4.69%
Institutional HolderSharesReport Date
Carlyle Group Inc.56,3282026-03-31
Geode Capital Management, LLC36,9132026-03-31
Vanguard Capital Management LLC32,9832026-03-31
Vanguard Fiduciary Trust Co13,1612026-03-31
Northern Trust Corporation10,6862026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CLGNCollPlant Biotechnologies Ltd. $3.51 -11.59% -0.37 $4.55M 0.00%
CVKDCadrenal Therapeutics, Inc. $0.91 -2.10% -0.19 $3.25M 0.00%
IBIOiBio, Inc. $0.87 -5.33% -3.46 $56.01M 0.00%
KLTOKlotho Neurosciences, Inc. $0.38 -7.10% -1.13 $20.08M 0.00%
MTVAMetaVia Inc. $1.41 +5.22% -0.38 $9.29M 0.00%

About Exicure, Inc.

Exicure, Inc. is led by CEO Jungsoo Kim, employs 7 people, headquartered in US, publicly traded since 2018.

Exicure, Inc. (XCUR) stock trades at $1.05 with a market capitalization of $6.69M. The stock is valued at a price-to-earnings (P/E) ratio of -0.87, price-to-book of 7.44, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.96 and $9.48, and currently trades 88.9% below its 52-week high.

On profitability, Exicure, Inc. generates a return on equity (ROE) of -237.91%, return on capital employed of -101.07%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides